HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anti-inflammatory activity of an imidazopyridine derivative (miroprofen).

Abstract
Anti-inflammatory activity of 2-[p-(2-imidazo[1,2-a]pyridyl) phenyl]propionic acid (Y-9213, miroprofen) was studied on various experimental models. Miroprofen was found to be as active as indomethacin against the exudative inflammation such as pleuritis in rats induced by Evans blue-carrageenin and the peritonitis in mice induced by acetic acid, and against the local Shwartzman reaction in rabbits. Miroprofen also inhibited the formation of edema induced by carrageenin or kaolin in rats' paws at lower doses. Against the proliferation of connective tissues, miroprofen showed the inhibitory action at higher doses. The ulcerogenic activity of miroprofen in rats was less potent than that of indomethacin, and as active as that of phenylbutazone. These findings indicate that miroprofen may be more effective in suppressing pain responses and acute inflammation accompanied with increased vascular permeability.
AuthorsY Maruyama, K Anami, M Terasawa, K Goto, T Imayoshi, Y Kadobe, Y Mizushima
JournalArzneimittel-Forschung (Arzneimittelforschung) Vol. 31 Issue 7 Pg. 1111-8 ( 1981) ISSN: 0004-4172 [Print] Germany
PMID7196760 (Publication Type: Journal Article)
Chemical References
  • Anti-Inflammatory Agents
  • Phenylpropionates
  • miroprofen
Topics
  • Animals
  • Anti-Inflammatory Agents (toxicity)
  • Arthritis, Experimental (prevention & control)
  • Capillary Permeability (drug effects)
  • Edema (prevention & control)
  • Granuloma (prevention & control)
  • Guinea Pigs
  • Male
  • Phenylpropionates (pharmacology, toxicity)
  • Rabbits
  • Rats
  • Stomach Ulcer (chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: